Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Biliary Tract Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04217954
What this trial is testing

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Who this might be right for
Advanced Biliary Tract Cancer
Peking University 32
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Not applicableLooking for participantsNCT06988592
What this trial is testing

GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）

Who this might be right for
Advanced Biliary Tract Cancer
Fudan University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05874414
What this trial is testing

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Genfit 98
Testing effectiveness (Phase 2)Study completedNCT01375972
What this trial is testing

Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma

Who this might be right for
Metastatic Biliary Cancer
Asan Medical Center 92
Early research (Phase 1)Study completedNCT00959127
What this trial is testing

ARRY-438162 (MEK162) in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsAdvanced or Metastatic Biliary CancerMetastatic Colorectal Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer 93
Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00661830
What this trial is testing

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

Who this might be right for
Adenocarcinoma
PD Dr Markus Möhler 103
Testing effectiveness (Phase 2)Looking for participantsNCT07062536
What this trial is testing

MFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line

Who this might be right for
Biliary Cancer Metastatic
Seoul National University Bundang Hospital 130
Testing effectiveness (Phase 2)Study completedNCT01943864
What this trial is testing

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

Who this might be right for
Cancer
GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT03314935
What this trial is testing

INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

Who this might be right for
Biliary Tract Cancer (BTC)Colorectal Cancer (CRC)Endometrial Cancer+3 more
Incyte Corporation 149
Not applicableStudy completedNCT04385147
What this trial is testing

Advanced Endoscopy During COVID-19

Who this might be right for
Cholangitis, Secondary BiliaryCholangiocarcinomaObstructive Jaundice+3 more
Al-Azhar University 670
Early research (Phase 1)Not Yet RecruitingNCT07252661
What this trial is testing

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more
AccSalus Biosciences, Inc. 40
Large-scale testing (Phase 3)Active Not RecruitingNCT03875235
What this trial is testing

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

Who this might be right for
Biliary Tract Neoplasms
AstraZeneca 810
Testing effectiveness (Phase 2)UnknownNCT00003296
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Brown University 26
Testing effectiveness (Phase 2)UnknownNCT04211168
What this trial is testing

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Who this might be right for
Advanced Biliary Tract Cancer
Peking Union Medical College Hospital 44
Testing effectiveness (Phase 2)Ended earlyNCT00422877
What this trial is testing

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Who this might be right for
Cancer of the Liver
American Regent, Inc. 13
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Not Yet RecruitingNCT07738939
What this trial is testing

IKS04 Regimen in Advanced Solid Tumors That Express CA242

Who this might be right for
Colorectal CancerGastro Esophageal Junctional CancerGastric Cancer (GC)+5 more
Iksuda Therapeutics Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Next Page